GlassScriptPhysician profile
Kamariah M Baker
NPI 1093296741
$2,927.47
in general payments reported to CMS, 2019-2025
39 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $740 · 2022: $1,072 · 2023: $697 · 2024: $213 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $528.87 | 2021-2023 | Senza |
| Abbvie INC. | $459.19 | 2021-2024 | |
| Merz Pharmaceuticals, LLC | $177.29 | 2021-2023 | Xeomin |
| Vertos Medical, INC. | $168.74 | 2021 | |
| Relievant Medsystems, INC. | $138.63 | 2022 | |
| Vanda Pharmaceuticals INC. | $134.23 | 2022-2023 | Hetlioz |
| Amgen INC. | $116.61 | 2021-2025 | Krystexxa, Evenity |
| Lilly USA, LLC | $92.59 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $82.45 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $79.86 | 2022 | |
| Medtronic, INC. | $74.69 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Biodelivery Sciences International, INC. | $69.47 | 2021 | |
| Alfasigma USA, INC. | $54.56 | 2021 | |
| Allergan, INC. | $53.66 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.26 | 2023 | Relistor |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamariah Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.